HEADER HYDROLASE 24-MAR-16 5IYT TITLE COMPLEX STRUCTURE OF EV-B93 MAIN PROTEASE 3C WITH N-ETHYL 4-((1- TITLE 2 CYCLOHEPTYL-1,2-DIHYDROPYRAZOL-3-ONE-5-YL)-AMINO)-4-OXO-2Z-BUTENAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: EV-B93 MAIN PROTEASE 3C; COMPND 3 CHAIN: A, B; COMPND 4 EC: 3.4.22.29,3.6.1.15,3.4.22.28; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ECHOVIRUS 1 (STRAIN HUMAN/EGYPT/FAROUK/1951); SOURCE 3 ORGANISM_COMMON: E-1; SOURCE 4 ORGANISM_TAXID: 103908; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PDEST KEYWDS 3C MAIN PROTEASE, ENTEROVIRUS B93, COVALENT INHIBITOR, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR Z.KACZMARSKA,D.BECKER,J.RADEMANN,M.COLL REVDAT 2 12-OCT-16 5IYT 1 JRNL REVDAT 1 05-OCT-16 5IYT 0 JRNL AUTH D.BECKER,Z.KACZMARSKA,C.ARKONA,R.SCHULZ,C.TAUBER,G.WOLBER, JRNL AUTH 2 R.HILGENFELD,M.COLL,J.RADEMANN JRNL TITL IRREVERSIBLE INHIBITORS OF THE 3C PROTEASE OF COXSACKIE JRNL TITL 2 VIRUS THROUGH TEMPLATED ASSEMBLY OF PROTEIN-BINDING JRNL TITL 3 FRAGMENTS. JRNL REF NAT COMMUN V. 7 12761 2016 JRNL REFN ESSN 2041-1723 JRNL PMID 27677239 JRNL DOI 10.1038/NCOMMS12761 REMARK 2 REMARK 2 RESOLUTION. 1.73 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0135 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.73 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.1 REMARK 3 NUMBER OF REFLECTIONS : 34781 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.189 REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.217 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1794 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.73 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.78 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2486 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.26 REMARK 3 BIN R VALUE (WORKING SET) : 0.2820 REMARK 3 BIN FREE R VALUE SET COUNT : 142 REMARK 3 BIN FREE R VALUE : 0.3400 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2832 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 23 REMARK 3 SOLVENT ATOMS : 182 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.17 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.17000 REMARK 3 B22 (A**2) : -0.72000 REMARK 3 B33 (A**2) : 0.43000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.14000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.123 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.115 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.081 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.555 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.962 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.955 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2963 ; 0.006 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 2875 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4009 ; 1.398 ; 1.970 REMARK 3 BOND ANGLES OTHERS (DEGREES): 6600 ; 0.861 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 374 ; 5.854 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 136 ;32.266 ;23.750 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 506 ;12.359 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 20 ;16.579 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 436 ; 0.071 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3385 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 708 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1466 ; 1.204 ; 2.721 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1465 ; 1.198 ; 2.720 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1832 ; 2.062 ; 4.074 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1833 ; 2.061 ; 4.075 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1497 ; 1.459 ; 3.023 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1498 ; 1.458 ; 3.025 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2172 ; 2.493 ; 4.437 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 3244 ; 5.069 ;22.707 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 3201 ; 4.946 ;22.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 5IYT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 24-MAR-16. REMARK 100 THE DEPOSITION ID IS D_1000219510. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-MAR-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALBA REMARK 200 BEAMLINE : XALOC REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.033 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 36576 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.730 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.1 REMARK 200 DATA REDUNDANCY : 2.700 REMARK 200 R MERGE (I) : 0.05600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.0500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.73 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.77 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.5 REMARK 200 DATA REDUNDANCY IN SHELL : 2.70 REMARK 200 R MERGE FOR SHELL (I) : 0.74300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.140 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3Q3X REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.42 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.13 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG3350, AMMONIUM ACETATE, BIS-TRIS, REMARK 280 PH 6.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 26.16500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 181 REMARK 465 GLU A 182 REMARK 465 GLN A 183 REMARK 465 HIS A 184 REMARK 465 HIS A 185 REMARK 465 HIS A 186 REMARK 465 HIS A 187 REMARK 465 HIS A 188 REMARK 465 HIS A 189 REMARK 465 GLU B 181 REMARK 465 GLU B 182 REMARK 465 GLN B 183 REMARK 465 HIS B 184 REMARK 465 HIS B 185 REMARK 465 HIS B 186 REMARK 465 HIS B 187 REMARK 465 HIS B 188 REMARK 465 HIS B 189 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 32 -118.67 48.09 REMARK 500 ASP A 32 -118.15 47.04 REMARK 500 PHE A 140 115.70 -169.96 REMARK 500 PRO A 141 83.86 -65.72 REMARK 500 ASP B 32 -121.52 54.53 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide NZN B 201 and CYS B REMARK 800 147 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3RUO RELATED DB: PDB REMARK 900 3RUO CONTAINS THE SAME PROTEIN COMPLEXED WITH RUPINTRIVIR (AG7088). REMARK 900 RELATED ID: 3Q3Y RELATED DB: PDB REMARK 900 3Q3Y CONTAINS THE SAME PROTEIN COMPLEXED WITH COMPOUND 1 (AG7404). REMARK 900 RELATED ID: 3Q3X RELATED DB: PDB REMARK 900 3Q3X CONTAINS THE SAME PROTEIN. DBREF 5IYT A 1 183 UNP O91734 POLG_EC01F 1540 1722 DBREF 5IYT B 1 183 UNP O91734 POLG_EC01F 1540 1722 SEQADV 5IYT MET A -1 UNP O91734 INITIATING METHIONINE SEQADV 5IYT LYS A 0 UNP O91734 EXPRESSION TAG SEQADV 5IYT VAL A 95 UNP O91734 ALA 1634 CONFLICT SEQADV 5IYT VAL A 137 UNP O91734 MET 1676 ENGINEERED MUTATION SEQADV 5IYT HIS A 184 UNP O91734 EXPRESSION TAG SEQADV 5IYT HIS A 185 UNP O91734 EXPRESSION TAG SEQADV 5IYT HIS A 186 UNP O91734 EXPRESSION TAG SEQADV 5IYT HIS A 187 UNP O91734 EXPRESSION TAG SEQADV 5IYT HIS A 188 UNP O91734 EXPRESSION TAG SEQADV 5IYT HIS A 189 UNP O91734 EXPRESSION TAG SEQADV 5IYT MET B -1 UNP O91734 INITIATING METHIONINE SEQADV 5IYT LYS B 0 UNP O91734 EXPRESSION TAG SEQADV 5IYT VAL B 95 UNP O91734 ALA 1634 CONFLICT SEQADV 5IYT VAL B 137 UNP O91734 MET 1676 ENGINEERED MUTATION SEQADV 5IYT HIS B 184 UNP O91734 EXPRESSION TAG SEQADV 5IYT HIS B 185 UNP O91734 EXPRESSION TAG SEQADV 5IYT HIS B 186 UNP O91734 EXPRESSION TAG SEQADV 5IYT HIS B 187 UNP O91734 EXPRESSION TAG SEQADV 5IYT HIS B 188 UNP O91734 EXPRESSION TAG SEQADV 5IYT HIS B 189 UNP O91734 EXPRESSION TAG SEQRES 1 A 191 MET LYS GLY PRO ALA PHE GLU PHE ALA VAL ALA MET MET SEQRES 2 A 191 LYS ARG ASN ALA SER THR VAL LYS THR GLU TYR GLY GLU SEQRES 3 A 191 PHE THR MET LEU GLY ILE TYR ASP ARG TRP ALA VAL LEU SEQRES 4 A 191 PRO ARG HIS ALA LYS PRO GLY PRO THR ILE LEU MET ASN SEQRES 5 A 191 ASP GLN GLU VAL GLY VAL LEU ASP ALA LYS GLU LEU VAL SEQRES 6 A 191 ASP LYS ASP GLY THR ASN LEU GLU LEU THR LEU LEU LYS SEQRES 7 A 191 LEU ASN ARG ASN GLU LYS PHE ARG ASP ILE ARG GLY PHE SEQRES 8 A 191 LEU ALA ARG GLU GLU VAL GLU VAL ASN GLU ALA VAL LEU SEQRES 9 A 191 ALA ILE ASN THR SER LYS PHE PRO ASN MET TYR ILE PRO SEQRES 10 A 191 VAL GLY GLN VAL THR ASP TYR GLY PHE LEU ASN LEU GLY SEQRES 11 A 191 GLY THR PRO THR LYS ARG MET LEU VAL TYR ASN PHE PRO SEQRES 12 A 191 THR ARG ALA GLY GLN CYS GLY GLY VAL LEU MET SER THR SEQRES 13 A 191 GLY LYS VAL LEU GLY ILE HIS VAL GLY GLY ASN GLY HIS SEQRES 14 A 191 GLN GLY PHE SER ALA ALA LEU LEU ARG HIS TYR PHE ASN SEQRES 15 A 191 GLU GLU GLN HIS HIS HIS HIS HIS HIS SEQRES 1 B 191 MET LYS GLY PRO ALA PHE GLU PHE ALA VAL ALA MET MET SEQRES 2 B 191 LYS ARG ASN ALA SER THR VAL LYS THR GLU TYR GLY GLU SEQRES 3 B 191 PHE THR MET LEU GLY ILE TYR ASP ARG TRP ALA VAL LEU SEQRES 4 B 191 PRO ARG HIS ALA LYS PRO GLY PRO THR ILE LEU MET ASN SEQRES 5 B 191 ASP GLN GLU VAL GLY VAL LEU ASP ALA LYS GLU LEU VAL SEQRES 6 B 191 ASP LYS ASP GLY THR ASN LEU GLU LEU THR LEU LEU LYS SEQRES 7 B 191 LEU ASN ARG ASN GLU LYS PHE ARG ASP ILE ARG GLY PHE SEQRES 8 B 191 LEU ALA ARG GLU GLU VAL GLU VAL ASN GLU ALA VAL LEU SEQRES 9 B 191 ALA ILE ASN THR SER LYS PHE PRO ASN MET TYR ILE PRO SEQRES 10 B 191 VAL GLY GLN VAL THR ASP TYR GLY PHE LEU ASN LEU GLY SEQRES 11 B 191 GLY THR PRO THR LYS ARG MET LEU VAL TYR ASN PHE PRO SEQRES 12 B 191 THR ARG ALA GLY GLN CYS GLY GLY VAL LEU MET SER THR SEQRES 13 B 191 GLY LYS VAL LEU GLY ILE HIS VAL GLY GLY ASN GLY HIS SEQRES 14 B 191 GLN GLY PHE SER ALA ALA LEU LEU ARG HIS TYR PHE ASN SEQRES 15 B 191 GLU GLU GLN HIS HIS HIS HIS HIS HIS HET NZN B 201 23 HETNAM NZN N-ETHYL 4-((1-CYCLOHEPTYL-1,2-DIHYDROPYRAZOL-3-ONE-5- HETNAM 2 NZN YL)-AMINO)-4-OXO-BUTANAMIDE FORMUL 3 NZN C16 H26 N4 O3 FORMUL 4 HOH *182(H2 O) HELIX 1 AA1 LYS A 0 ASN A 14 1 15 HELIX 2 AA2 HIS A 40 LYS A 42 5 3 HELIX 3 AA3 ILE A 86 LEU A 90 5 5 HELIX 4 AA4 LEU A 175 ASN A 180 5 6 HELIX 5 AA5 LYS B 0 ASN B 14 1 15 HELIX 6 AA6 HIS B 40 LYS B 42 5 3 HELIX 7 AA7 ILE B 86 LEU B 90 5 5 HELIX 8 AA8 LEU B 175 ASN B 180 5 6 SHEET 1 AA1 7 ALA A 15 THR A 20 0 SHEET 2 AA1 7 GLY A 23 TYR A 31 -1 O PHE A 25 N VAL A 18 SHEET 3 AA1 7 TRP A 34 PRO A 38 -1 O TRP A 34 N TYR A 31 SHEET 4 AA1 7 ASN A 69 ASN A 78 -1 O THR A 73 N LEU A 37 SHEET 5 AA1 7 GLN A 52 VAL A 63 -1 N GLY A 55 O ASN A 78 SHEET 6 AA1 7 THR A 46 MET A 49 -1 N MET A 49 O GLN A 52 SHEET 7 AA1 7 ALA A 15 THR A 20 -1 N LYS A 19 O LEU A 48 SHEET 1 AA2 7 VAL A 97 ILE A 104 0 SHEET 2 AA2 7 MET A 112 LEU A 127 -1 O MET A 112 N ILE A 104 SHEET 3 AA2 7 THR A 130 ASN A 139 -1 O THR A 132 N LEU A 125 SHEET 4 AA2 7 GLN A 168 ALA A 173 -1 O SER A 171 N LEU A 136 SHEET 5 AA2 7 LYS A 156 GLY A 164 -1 N VAL A 162 O PHE A 170 SHEET 6 AA2 7 VAL A 150 SER A 153 -1 N LEU A 151 O GLY A 159 SHEET 7 AA2 7 VAL A 97 ILE A 104 -1 N VAL A 101 O MET A 152 SHEET 1 AA3 7 ALA B 15 THR B 20 0 SHEET 2 AA3 7 GLY B 23 TYR B 31 -1 O PHE B 25 N VAL B 18 SHEET 3 AA3 7 TRP B 34 PRO B 38 -1 O TRP B 34 N TYR B 31 SHEET 4 AA3 7 ASN B 69 ASN B 78 -1 O THR B 73 N LEU B 37 SHEET 5 AA3 7 GLN B 52 VAL B 63 -1 N GLY B 55 O ASN B 78 SHEET 6 AA3 7 THR B 46 MET B 49 -1 N MET B 49 O GLN B 52 SHEET 7 AA3 7 ALA B 15 THR B 20 -1 N LYS B 19 O LEU B 48 SHEET 1 AA4 7 VAL B 97 ILE B 104 0 SHEET 2 AA4 7 MET B 112 LEU B 127 -1 O MET B 112 N ILE B 104 SHEET 3 AA4 7 THR B 130 ASN B 139 -1 O THR B 132 N LEU B 125 SHEET 4 AA4 7 GLN B 168 ALA B 173 -1 O SER B 171 N LEU B 136 SHEET 5 AA4 7 LYS B 156 ASN B 165 -1 N GLY B 163 O PHE B 170 SHEET 6 AA4 7 VAL B 150 SER B 153 -1 N LEU B 151 O GLY B 159 SHEET 7 AA4 7 VAL B 97 ILE B 104 -1 N VAL B 101 O MET B 152 LINK SG CYS B 147 C26 NZN B 201 1555 1555 1.79 SITE 1 AC1 14 PHE B 25 HIS B 40 THR B 142 ARG B 143 SITE 2 AC1 14 ALA B 144 GLY B 145 GLN B 146 GLY B 148 SITE 3 AC1 14 GLY B 149 HIS B 161 VAL B 162 GLY B 164 SITE 4 AC1 14 HOH B 339 HOH B 360 CRYST1 57.460 52.330 62.270 90.00 103.73 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017403 0.000000 0.004251 0.00000 SCALE2 0.000000 0.019109 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016531 0.00000 MASTER 293 0 1 8 28 0 4 6 0 0 0 30 END